EcoDrugPlus

Ensembl ID : ENSMLUG00000024052
Gene Symbol: -
Cross references: -
204 Possible Orthologues:

Ensembl ID : ENSMLUG00000024130
Gene Symbol: -
Cross references: -
152 Possible Orthologues:

Ensembl ID : ENSMLUG00000024762
Gene Symbol: -
Cross references: -
158 Possible Orthologues:

Ensembl ID : ENSMLUG00000025590
Gene Symbol: -
Cross references: -
121 Possible Orthologues:

Ensembl ID : ENSMLUG00000026194
Gene Symbol: -
Cross references: -
164 Possible Orthologues:

Ensembl ID : ENSMLUG00000026530
Gene Symbol: -
Cross references: -
132 Possible Orthologues:

Ensembl ID : ENSMLUG00000026837
Gene Symbol: -
Cross references: -
154 Possible Orthologues:

Ensembl ID : ENSMLUG00000027857
Gene Symbol: -
Cross references: -
327 Possible Orthologues:

Ensembl ID : ENSMLUG00000027927
Gene Symbol: -
Cross references: -
121 Possible Orthologues:

Ensembl ID : ENSMLUG00000023730
Gene Symbol: -
Cross references: -
63 Possible Orthologues:

Ensembl ID : ENSMLUG00000014036
Gene Symbol: -
Cross references: -
235 Possible Orthologues:

Ensembl ID : ENSMLUG00000007716
Gene Symbol: -
Cross references: -
451 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).